Results 291 to 300 of about 273,161 (350)
Some of the next articles are maybe not open access.

Non-Hodgkin lymphoma

The Lancet, 2012
Lymphomas are solid tumours of the immune system. Hodgkin's lymphoma accounts for about 10% of all lymphomas, and the remaining 90% are referred to as non-Hodgkin lymphoma. Non-Hodgkin lymphomas have a wide range of histological appearances and clinical features at presentation, which can make diagnosis difficult.
Kate R, Shankland   +2 more
openaire   +2 more sources

Non-Hodgkin's lymphoma

Medicine, 2000
Abstract Non-Hodgkin's lymphoma (NHL) is a heterogeneous group of malignant diseases characterized by replacement of normal lymphoid structure by diffuse and nodular collections of abnormal lymphocytes.
Claire Dearden, Estella Matutes
openaire   +1 more source

Non-Hodgkin lymphoma

The Lancet, 2003
Non-Hodgkin lymphoma is a non-specific term that includes several lymphoproliferative malignant diseases with different clinical and histological appearances. Here, we concentrate on adult lymphomas. We look at their molecular basis, at the development of a classification system based on a better understanding of the biology of the various subgroups ...
Linda S, Evans, Barry W, Hancock
openaire   +2 more sources

Non-Hodgkin's lymphomas

Medical Clinics of North America, 1984
The non-Hodgkin's lymphomas, although sharing a common origin, often present physicians with wide variations in natural history and prognosis. The proper therapy of these diseases is based on an understanding of these differences and upon the information gained by pathologic review and staging, as well as the available chemotherapeutic and ...
openaire   +2 more sources

Non-Hodgkin's Lymphoma

2003
It is estimated that 56,200 new cases of non-Hodgkin’ s lymphoma (NHL) were diagnosed in the United States in 2001, and approx 26,300 people died from NHL, which makes it the fifth leading cause of cancer death in men and the sixth leading cause of cancer death among women (1).
Igor Espinoza-Delgado, Dan L. Longo
openaire   +1 more source

Pediatric non-Hodgkin lymphoma

Current Hematologic Malignancy Reports, 2007
Non-Hodgkin's lymphoma (NHL) accounts for 7% of cancer in children and adolescents in the United States, or approximately 1000 cases annually. NHL in the pediatric population differs from that observed in adult patients with respect to staging systems, histologic subtypes of disease, treatment, and outcomes.
Thomas G, Gross, Amanda M, Termuhlen
openaire   +3 more sources

Non-Hodgkinʼs lymphoma

Current Opinion in Hematology, 1996
Attention is being directed at increasing the intensity of therapy as a means of improving the results of primary therapy for non-Hodgkin's lymphoma. There is increasing evidence that the use of high-dose consolidation therapy followed by autologous hematopoietic rescue in first remission improves survival in high-risk patients.
P J, Bierman, J O, Armitage
openaire   +2 more sources

Intraocular non-Hodgkin's lymphoma

Documenta Ophthalmologica, 1990
Usually eye symptoms precede the infiltration of non-Hodgkin's lymphoma in the central nervous system or in other organs. Early treatment of the tumor by irradiation, to which it is highly sensitive, can preserve the vision and prolong the life of the patient.
Hooymans, JMM, Timmerman, Z
openaire   +3 more sources

Non-Hodgkin’s lymphoma

Nursing Standard, 2016
Essential facts Non-Hodgkin's lymphoma (NHL) is a cancer of the lymphatic system. According to Cancer Research UK, it is the sixth most common cancer in the UK, with 13,413 new cases diagnosed in 2013. There were 4,801 deaths from NHL in 2014. The disease has many subtypes, with two main broad categories: high-grade or aggressive and low-grade or ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy